IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0236559.html
   My bibliography  Save this article

Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study

Author

Listed:
  • Elizabeth G Bond
  • Lusine Abrahamyan
  • Mohammad K A Khan
  • Andrea Gershon
  • Murray Krahn
  • Ping Li
  • Rajibul Mian
  • Nicholas Mitsakakis
  • Mohsen Sadatsafavi
  • Teresa To
  • Petros Pechlivanoglou
  • for the Canadian Respiratory Research Network

Abstract

Chronic obstructive pulmonary disease (COPD) poses a significant but heterogeneous burden to individuals and healthcare systems. Policymakers develop targeted policies to minimize this burden but need personalized tools to evaluate novel interventions and target them to subpopulations most likely to benefit. We developed a platform to identify subgroups that are at increased risk of emergency department visits, hospitalizations and mortality and to provide stratified patient input in economic evaluations of COPD interventions. We relied on administrative and survey data from Ontario, Canada and applied a combination of microsimulation and multi-state modeling methods. We illustrated the functionality of the platform by quantifying outcomes across smoking status (current, former, never smokers) and by estimating the effect of smoking cessation on resource use and survival, by comparing outcomes of hypothetical cohorts of smokers who quit at diagnosis and smokers that continued to smoke post diagnosis. The cumulative incidence of all-cause mortality was 37.9% (95% CI: 34.9, 41.4) for never smokers, 34.7% (95% CI: 32.1, 36.9) for current smokers, and 46.4% (95% CI: 43.6, 49.0) for former smokers, at 14 years. Over 14 years, smokers who did not quit at diagnosis had 16.3% (95% CI: 9.6, 38.4%) more COPD-related emergency department visits than smokers who quit at diagnosis. In summary, we combined methods from clinical and economic modeling to create a novel tool that policymakers and health economists can use to inform future COPD policy decisions and quantify the effect of modifying COPD risk factors on resource utilization and morality.

Suggested Citation

  • Elizabeth G Bond & Lusine Abrahamyan & Mohammad K A Khan & Andrea Gershon & Murray Krahn & Ping Li & Rajibul Mian & Nicholas Mitsakakis & Mohsen Sadatsafavi & Teresa To & Petros Pechlivanoglou & for t, 2020. "Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-16, August.
  • Handle: RePEc:plo:pone00:0236559
    DOI: 10.1371/journal.pone.0236559
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0236559
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0236559&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0236559?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Mehdi Najafzadeh & Carlo A Marra & Larry D Lynd & Mohsen Sadatsafavi & J Mark FitzGerald & Bruce McManus & Don Sin, 2012. "Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model," PLOS ONE, Public Library of Science, vol. 7(10), pages 1-12, October.
    2. Tristan Snowsill, 2019. "A New Method for Model-Based Health Economic Evaluation Utilizing and Extending Moment-Generating Functions," Medical Decision Making, , vol. 39(5), pages 523-539, July.
    3. Andrew H. Briggs & Timothy Baker & Nancy A. Risebrough & Mike Chambers & Sebastian Gonzalez-McQuire & Afisi S. Ismaila & Alex Exuzides & Chris Colby & Maggie Tabberer & Hana Muellerova & Nicholas Loca, 2017. "Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model," Medical Decision Making, , vol. 37(4), pages 469-480, May.
    4. Jackson, Christopher, 2016. "flexsurv: A Platform for Parametric Survival Modeling in R," Journal of Statistical Software, Foundation for Open Access Statistics, vol. 70(i08).
    5. Elkan F. Halpern & Milton C. Weinstein & Maria G.M. Hunink & G. Scott Gazelle, 2000. "Representing Both First- and Second-order Uncertainties by Monte Carlo Simulation for Groups of Patients," Medical Decision Making, , vol. 20(3), pages 314-322, July.
    6. Mohsen Sadatsafavi & Shahzad Ghanbarian & Amin Adibi & Kate Johnson & J. Mark FitzGerald & William Flanagan & Stirling Bryan & Don Sin, 2019. "Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada," Medical Decision Making, , vol. 39(2), pages 152-167, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Montserrat Vera-Llonch & Ellen Dukes & Javier Rejas & Oleg Sofrygin & Marko Mychaskiw & Gerry Oster, 2010. "Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(1), pages 35-44, February.
    2. Mehdi Najafzadeh & Carlo Marra & Eleni Galanis & David Patrick, 2009. "Cost Effectiveness of Herpes Zoster Vaccine in Canada," PharmacoEconomics, Springer, vol. 27(12), pages 991-1004, December.
    3. Niklas Zethraeus & Magnus Johannesson & Bengt Jönsson & Mickael Löthgren & Magnus Tambour, 2003. "Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies," PharmacoEconomics, Springer, vol. 21(1), pages 39-48, January.
    4. Sharples, Linda D., 2018. "The role of statistics in the era of big data: Electronic health records for healthcare research," Statistics & Probability Letters, Elsevier, vol. 136(C), pages 105-110.
    5. Suvra Pal & Hongbo Yu & Zachary D. Loucks & Ian M. Harris, 2020. "Illustration of the Flexibility of Generalized Gamma Distribution in Modeling Right Censored Survival Data: Analysis of Two Cancer Datasets," Annals of Data Science, Springer, vol. 7(1), pages 77-90, March.
    6. Burger, Rulof & Ito, Seiro, 2016. "Labour market turnovers among South African youths," IDE Discussion Papers 603, Institute of Developing Economies, Japan External Trade Organization(JETRO).
    7. Sankararaman, S. & Mahadevan, S., 2013. "Separating the contributions of variability and parameter uncertainty in probability distributions," Reliability Engineering and System Safety, Elsevier, vol. 112(C), pages 187-199.
    8. Daniel Gallacher & Peter Kimani & Nigel Stallard, 2021. "Extrapolating Parametric Survival Models in Health Technology Assessment Using Model Averaging: A Simulation Study," Medical Decision Making, , vol. 41(4), pages 476-484, May.
    9. Fernando Alarid-Escudero & Eline M. Krijkamp & Eva A. Enns & Alan Yang & M. G. Myriam Hunink & Petros Pechlivanoglou & Hawre Jalal, 2021. "A Tutorial on Time-Dependent Cohort State-Transition Models in R using a Cost-Effectiveness Analysis Example," Papers 2108.13552, arXiv.org, revised Jun 2022.
    10. Vinaytosh Mishra & Mohita G. Sharma, 2020. "Understanding Humanitarian Supply Chain Through Causal Modelling," South Asian Journal of Business and Management Cases, , vol. 9(3), pages 317-329, December.
    11. Michael Crowther & Paul Lambert, 2016. "Multistate survival analysis in Stata," United Kingdom Stata Users' Group Meetings 2016 02, Stata Users Group.
    12. Fuino, Michel & Wagner, Joël, 2020. "Duration of long-term care: Socio-economic factors, type of care interactions and evolution," Insurance: Mathematics and Economics, Elsevier, vol. 90(C), pages 151-168.
    13. I. Oostrum & T. A. Russell-Smith & M. Jakobsson & J. Torup Østby & B. Heeg, 2022. "Cost-Effectiveness of Inotuzumab Ozogamicin Compared to Standard of Care Chemotherapy for Treating Relapsed or Refractory Acute Lymphoblastic Leukaemia Patients in Norway and Sweden," PharmacoEconomics - Open, Springer, vol. 6(1), pages 47-62, January.
    14. Lauren Scott & Chris Rogers, 2016. "Creating summary tables using the sumtable command," United Kingdom Stata Users' Group Meetings 2016 05, Stata Users Group.
    15. Machado, Robson J.M. & van den Hout, Ardo & Marra, Giampiero, 2021. "Penalised maximum likelihood estimation in multi-state models for interval-censored data," Computational Statistics & Data Analysis, Elsevier, vol. 153(C).
    16. Francesco Grossetti & Francesca Ieva & Anna Maria Paganoni, 2018. "A multi-state approach to patients affected by chronic heart failure," Health Care Management Science, Springer, vol. 21(2), pages 281-291, June.
    17. Sarazin, Gabriel & Morio, Jérôme & Lagnoux, Agnès & Balesdent, Mathieu & Brevault, Loïc, 2021. "Reliability-oriented sensitivity analysis in presence of data-driven epistemic uncertainty," Reliability Engineering and System Safety, Elsevier, vol. 215(C).
    18. Michał Narajewski & Florian Ziel, 2019. "Estimation and Simulation of the Transaction Arrival Process in Intraday Electricity Markets," Energies, MDPI, vol. 12(23), pages 1-16, November.
    19. Sankararaman, Shankar & Mahadevan, Sankaran, 2011. "Likelihood-based representation of epistemic uncertainty due to sparse point data and/or interval data," Reliability Engineering and System Safety, Elsevier, vol. 96(7), pages 814-824.
    20. Sandra Tunis & Luc Sauriol & Michael Minshall, 2010. "Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada," Applied Health Economics and Health Policy, Springer, vol. 8(4), pages 267-280, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0236559. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.